SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                  ------------

                                    FORM 10-Q

(Mark One)

|X| Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 For The Quarter Ended March 31, 2000
                    ----------------------------
or

|_| Transition report pursuant to Section 13 or 15(d) of the Securities Exchange
Act of 1934 For The Transition Period from ______to______

Commission File Number 0-22261

                        LEXINGTON HEALTHCARE GROUP, INC.
                        --------------------------------
             (Exact name of registrant as specified in its charter)

Delaware                                                     06-1468252
- --------                                                     ----------
(State or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                               identification No.)

1577 New Britain Avenue, Farmington, CT                      06032
- ---------------------------------------                      -----
(Address of principal executive offices)                     (Zip Code)

Registrant's telephone number, including area code: 860-674-2700
                                                    ------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. Yes  |X|  No  |_|

                      APPLICABLE ONLY TO CORPORATE ISSUERS

State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date: May 12, 2000 3,525,000 Shares of
Common Stock outstanding



                        LEXINGTON HEALTHCARE GROUP, INC.
                            March 31, 2000 FORM 10-Q
                                      INDEX

Part I -- Financial Information

Item 1.  Condensed Consolidated Financial Statements

         Condensed Consolidated Balance Sheets -- March 31, 2000 and
         June 30, 1999....................................................Pg. 3.

         Condensed Consolidated Statements of Operations -- Nine
         months and three months ended March 31, 2000 and 1999............Pg. 4.

         Condensed Consolidated Statements of Cash Flows -- Nine
         months ended March 31, 2000 and 1999.............................Pg. 5.

         Notes to Condensed Consolidated Financial Statements...........Pg. 6-9.

Item 2.  Management's Discussion and Analysis of Financial
         Condition and Results of Operations..........................Pg. 10-15.

Part II -- Other Information

Item 1.  Legal Proceedings...............................................Pg. 16.

Item 2.  Changes in Securities...........................................Pg. 16.

Item 3.  Defaults Upon Senior Securities.................................Pg. 16.

Item 4.  Submission of Matters to a Vote of Security Holders.............Pg. 17.

Item 5.  Other Information...............................................Pg. 17.

Item 6.  Exhibits and Reports on Form 8-K................................Pg. 17.

Signatures...............................................................Pg. 17.


                                                                         Page 2.


               LEXINGTON HEALTHCARE GROUP, INC. AND SUBSIDIARIES
                     CONDENSED CONSOLIDATED BALANCE SHEETS



                                                                            March 31,       June 30,
                                                                              2000            1999
                                                                          (Unaudited)      (Audited)
                                                                          ------------    ------------
                                                                                    
                                ASSETS
CURRENT ASSETS
     Cash and cash equivalents                                            $  1,388,000    $  3,675,000
     Accounts  receivable, net of allowance for doubtful
        accounts of $801,000 and $848,000, respectively                     15,117,000      16,092,000
     Inventories                                                               940,000       1,058,000
     Prepaid expenses and other current assets                               1,354,000       1,031,000
                                                                          ------------    ------------
            Total current assets                                            18,799,000      21,856,000

PROPERTY, EQUIPMENT & LEASEHOLD
IMPROVEMENTS, net                                                            4,408,000       4,147,000

OTHER ASSETS
      Goodwill, net                                                          2,886,000       3,013,000
      Security deposits - related parties                                    2,337,000       2,337,000
      Security deposits - other                                                543,000         371,000
      Bed licenses, net                                                      1,423,000       1,510,000
      Operating subsidy receivable (less current portion)                      299,000         555,000
      Other assets, net                                                        217,000          91,000
      Residents' funds                                                         388,000         403,000
                                                                          ------------    ------------
                                                                             8,093,000       8,280,000
                                                                          ------------    ------------
                                                                          $ 31,300,000    $ 34,283,000
                                                                          ============    ============

                 LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
      Accounts payable and accrued expenses                               $ 11,604,000    $ 13,473,000
      Due to SunBridge - purchased receivables                               2,157,000       2,582,000
      Estimated third-party payor settlements                                  331,000         939,000
      Notes and capital leases payable (current portion)                     3,840,000       3,867,000
      Income taxes payable                                                      25,000          40,000
                                                                          ------------    ------------
            Total current liabilities                                       17,957,000      20,901,000

OTHER LIABILITIES
      Notes and capital leases payable (less current portion)                7,754,000       7,768,000
      Deferred rent                                                            708,000         314,000
      Residents' funds payable                                                 388,000         403,000
      Other liabilities                                                        120,000         120,000
                                                                          ------------    ------------
                                                                             8,970,000       8,605,000
                                                                          ------------    ------------
            Total liabilities                                               26,927,000      29,506,000
                                                                          ------------    ------------

MINORITY INTEREST                                                              656,000         545,000

STOCKHOLDERS' EQUITY
      Common stock, par value $.01 per share, authorized
      15,000,000 shares, issued 4,125,000 shares                                41,000          41,000
      Additional paid-in capital                                             6,126,000       6,126,000
      Note receivable - related party                                               --        (574,000)
      Treasury stock, at cost, 600,000 shares                                 (576,000)             --
      Deficit                                                               (1,874,000)     (1,361,000)
                                                                          ------------    ------------
            Total stockholders' equity                                       3,717,000       4,232,000
                                                                          ------------    ------------
                                                                          $ 31,300,000    $ 34,283,000
                                                                          ============    ============


         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.


                                                                         Page 3.


                LEXINGTON HEALTHCARE GROUP, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
                                   (UNAUDITED)



                                                                     Nine months ended             Three months ended
                                                                         March 31,                      March 31,
                                                                         ---------                      ---------

                                                                   2000            1999            2000            1999
                                                                   ----            ----            ----            ----
                                                                                                  
REVENUES
    Net patient service revenue                               $ 55,586,000    $ 44,474,000    $ 19,436,000    $ 14,226,000
    Management fee revenue                                       4,478,000      10,958,000         (87,000)      6,362,000
    Other revenue                                                  250,000         285,000         114,000         116,000
                                                              ------------    ------------    ------------    ------------
            Total revenues                                      60,314,000      55,717,000      19,463,000      20,704,000

EXPENSES
    Operating expenses:
      Salaries and benefits                                     44,038,000      40,335,000      14,319,000      15,323,000
      Food, medical and other supplies                           6,295,000       5,693,000       2,094,000       2,000,000
      Other operating expenses                                   7,126,000       6,142,000       2,564,000       2,342,000
    Corporate, general and administrative expenses               2,367,000       2,221,000         686,000         787,000
    Interest expense                                               890,000         751,000         310,000         270,000
                                                              ------------    ------------    ------------    ------------
            Total expenses                                      60,716,000      55,142,000      19,973,000      20,722,000
                                                              ------------    ------------    ------------    ------------

    Income (loss) before income taxes and minority interest       (402,000)        575,000        (510,000)        (18,000)

PROVISION FOR (BENEFIT FROM) INCOME TAXES                               --          92,000          (2,000)        (31,000)

MINORITY INTEREST IN INCOME OF CONSOLIDATED
      JOINT VENTURES                                              (111,000)       (253,000)        (10,000)         34,000
                                                              ------------    ------------    ------------    ------------

    Net income (loss)                                         $   (513,000)   $    230,000    $   (518,000)   $     47,000
                                                              ============    ============    ============    ============

    Basic earnings (loss) per common share                    $      (0.14)   $       0.06    $      (0.15)   $       0.01
                                                              ============    ============    ============    ============

    Weighted average number of common shares outstanding         3,582,000       4,125,000       3,525,000       4,125,000
                                                              ============    ============    ============    ============


         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.


                                                                         Page 4.


                LEXINGTON HEALTHCARE GROUP, INC. AND SUBSIDIARIES
                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                FOR THE NINE MONTHS ENDED MARCH 31, 2000 AND 1999

                                  (UNAUDITED)


                                                                                          2000           1999
                                                                                          ----           ----
                                                                                               
CASH FLOWS FROM OPERATING ACTIVITIES
   Net (loss) income                                                                  $  (513,000)   $   230,000
   Adjustments to reconcile net income (loss) to net cash
      (used in) provided by operating activities                                          585,000        509,000
   Minority interest in income of consolidated joint ventures                             111,000        253,000
   Decrease (increase) in accounts receivable                                             975,000     (2,596,000)
   (Decrease) increase in accounts payable and accrued expenses                        (1,869,000)     1,928,000
   (Decrease) increase in due to SunBridge - purchased receivables                       (425,000)     2,632,000
   Changes in other operating assets and liabilities                                     (322,000)    (1,996,000)
                                                                                      -----------    -----------
            Net cash (used in) provided by operating activities                        (1,458,000)       960,000
                                                                                      -----------    -----------

CASH FLOWS FROM INVESTING ACTIVITIES
    Note receivable - related party                                                        (2,000)       (87,000)
    Repayments of note receivable - related party                                              --         60,000
    Increase in security deposits - other                                                (172,000)            --
    Acquisition of fixed assets                                                          (418,000)      (513,000)
                                                                                      -----------    -----------
            Net cash used in investing activities                                        (592,000)      (540,000)
                                                                                      -----------    -----------

CASH FLOWS FROM FINANCING ACTIVITIES
    (Repayments of) proceeds from line of credit - net                                    (28,000)     2,350,000
    Repayments of notes payable and capital lease obligations                            (209,000)      (182,000)
                                                                                      -----------    -----------
            Net cash (used in) provided by financing activities                          (237,000)     2,168,000
                                                                                      -----------    -----------

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS                                   (2,287,000)     2,588,000

CASH AND CASH EQUIVALENTS, beginning of period                                          3,675,000        831,000
                                                                                      -----------    -----------

CASH AND CASH EQUIVALENTS, end of period                                              $ 1,388,000    $ 3,419,000
                                                                                      ===========    ===========

  NON-CASH INVESTING AND FINANCING ACTIVITIES:

    Certain assets acquired through assumption of mortgage note payable               $   163,000    $   362,000
    Equipment and leasehold improvements acquired through assumption
     of notes payable and capital leases                                                   33,000        110,000
    Receipt of treasury stock in satisfaction of note receivable - related party          576,000             --


         The accompanying notes are an integral part of these condensed
                       consolidated financial statements.


                                                                         Page 5.


                LEXINGTON HEALTHCARE GROUP, INC. AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
    (Information with respect to March 31, 2000 and for the three months and
             nine months ended March 31, 2000 and 1999 is unaudited)

NOTE A - THE COMPANY

The condensed consolidated financial statements include the accounts of
Lexington Healthcare Group, Inc. and all of its wholly-owned subsidiaries: Balz
Medical Services, Inc. ("BALZ"), Professional Relief Nurses, Inc. ("PRN"),
Lexington Highgreen Holding, Inc., and LexiCore Rehab Services, LLC
("Lexicore"), collectively, the "Company", as well as the accounts of Lexicon
Pharmacy Services, LLC ("Lexicon"), a 70% owned joint venture controlled by the
Company. All material intercompany balances and transactions have been
eliminated in consolidation.

The Company is a long-term and subacute care provider which operates eight
nursing home facilities at March 31, 2000 with 1,063 beds licensed by the State
of Connecticut. BALZ provides medical supplies and durable medical equipment to
nursing homes ; PRN provides health care services in the homes of its patients.
Lexicore and Lexicon provide rehab and pharmacy services respectively to
patients in the Company's and other nursing homes.

NOTE B - BASIS OF PRESENTATION

The financial information included herein is unaudited, except as discussed
below, and is presented on a condensed basis; however, the information reflects
all adjustments (consisting solely of normal recurring adjustments) that are, in
the opinion of management, necessary to present fairly the financial position,
results of operations, and cash flows for the interim periods presented although
the results shown for the interim periods presented herein are not necessarily
indicative of the results to be obtained for a full fiscal year. The condensed
balance sheet data as of June 30, 1999 is derived from audited financial
statements; certain line items have been combined or condensed in their
presentation herein.

Inventories consisting of food, chemicals and medical and other supplies are
valued at the lower of cost or market, with cost determined on a first-in,
first-out (FIFO) basis.

NOTE C - REORGANIZATION, PUBLIC STOCK OFFERING, ACQUISITIONS AND NEW BUSINESSES

Lexington Healthcare Group, Inc. was incorporated in 1996. It completed an
initial public offering of its common stock in May 1997 during which 1,125,000
shares of common stock at $5 per share and 1,940,625 common stock warrants at
$.10 per warrant were issued resulting in net proceeds to the Company of $4.1
million. Upon completion of such offering, the Company became the successor to
Lexington Health Care Group, LLC, a limited liability company ("LLC"). The
business combination was accounted for as a reorganization of entities under
common control, in a manner similar to a pooling of interests, using LLC's
historical cost basis.


                                                                         Page 6.


                LEXINGTON HEALTHCARE GROUP, INC. AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
    (Information with respect to March 31, 2000 and for the three months and
             nine months ended March 31, 2000 and 1999 is unaudited)

NOTE C - REORGANIZATION, PUBLIC STOCK OFFERING, ACQUISITIONS AND NEW BUSINESSES
(Continued)

On October 15, 1997 Lexicore Rehab Services, LLC began operations as a 50% owned
joint venture with Core Rehab Management, LLC. The joint venture was controlled
by the Company and the results of its operations from inception are included in
the Company's condensed consolidated financial statements with appropriate
recognition of minority interest. As of January 1, 1999, the Company acquired
the remaining 50% membership interest for a nominal amount plus $120,000 of
residual payments which are payable based on the occurrence of certain future
events. Henceforth the Company accounted for Lexicore's operations as a
wholly-owned subsidiary; minority interest has been adjusted accordingly.

On December 1, 1997 Lexicon Pharmacy Services, LLC began operations as a 70%
owned joint venture with Pharmacy Corporation of America. The joint venture is
controlled by the Company and the results of its operations from inception are
included in the Company's condensed consolidated financial statements with
appropriate recognition of minority interest. In January 2000, the Company
agreed with its joint venture partner to terminate operations as of March 31,
2000. The Company has begun working with an unrelated company to receive
pharmaceutical services.

On November 1, 1998 the Company began providing management services for four
skilled nursing facilities in Connecticut under an interim Management Agreement
with SunBridge Healthcare Corporation ("SunBridge"), a New Mexico corporation
and nation-wide healthcare provider.

As consideration for the services provided under this Management Agreement, the
Company was entitled to retain the excess of any revenues earned in the delivery
of patient services over the expenses incurred during the term and was
responsible for any excess of expenses incurred over revenues earned in the
operation of the facilities during the term. Under the terms of the agreement
SunBridge retained responsibility for all building lease costs. In addition, the
Company purchased substantially all of SunBridge's accounts receivable for these
facilities. As of March 31, 2000, the balance owed is presented as "Due to
SunBridge - purchased receivables" in the accompanying condensed consolidated
balance sheet.

Effective September 1, 1999, the Company acquired the operations of two of the
managed facilities, Adams House and Heritage Heights; the buildings are leased
with an option to purchase. These facilities have a total of 240 skilled nursing
beds. Management contracts covering the two other SunBridge facilities with a
total of 239 skilled nursing beds were terminated as of August 31, 1999 and the
operations of those facilities were returned to SunBridge.


                                                                         Page 7.


                LEXINGTON HEALTHCARE GROUP, INC. AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
    (Information with respect to March 31, 2000 and for the three months and
             nine months ended March 31, 2000 and 1999 is unaudited)

NOTE C - REORGANIZATION, PUBLIC STOCK OFFERING, ACQUISITIONS AND NEW BUSINESSES
(Continued)

Under the terms of the management agreement, which terminated on August 31,
1999, the Company earned management fees of $4,426,000 and incurred costs and
expenses of $4,407,000 during the two months ended August 31, 1999.

NOTE D - NOTE RECEIVABLE-RELATED PARTY AND TREASURY STOCK

In July 1999, the Company, pursuant to Board of Director's approval, defaulted
an 8% interest-bearing promissory note due from an officer and director of the
Company and seized the collateral of 600,000 shares of the Company's common
stock in satisfaction of the note and interest due. The shares received have
been put into the Company's treasury.

The 600,000 shares had a market bid price of $731,000 at the time of their
surrender and the note and accumulated interest had a carrying value of
$576,000. The Company's Board of Directors considers the difference between the
market price and carrying value of the note receivable of $155,000 to be a
reasonable and fair discount for the shares received.

NOTE E - RENEGOTIATION OF RELATED PARTY OPERATING LEASE

The Company leases four of its nursing facilities (including certain equipment)
under an operating lease with a partnership related through common ownership.
The lease agreement, as amended, commenced on July 1, 1995 and is for an
eighteen-year period, with renewal options for up to thirteen years. Annual
rentals under the lease are currently $2.5 million.

The Company has renegotiated the required rent payments covering the period of
October 1999 through February 2001 which will reduce the rent due during that
period by approximately $800,000. However, recognition of that expense reduction
will be accounted for over the remaining fourteen-year term of the lease.

Rent expense charged to operations under this related party operating lease
aggregated $1,840,000 and $1,853,000 for the nine months ended March 31, 2000
and 1999, respectively.


                                                                         Page 8.


                LEXINGTON HEALTHCARE GROUP, INC. AND SUBSIDIARIES
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
    (Information with respect to March 31, 2000 and for the three months and
             nine months ended March 31, 2000 and 1999 is unaudited)

NOTE F - CONTINGENCIES

In October 1999, the Company announced that certain employees of the Company
were served with a subpoena by the Office of the U.S. Attorney to testify before
a grand jury in the U.S. District Court, District of Connecticut. The Company
and certain members of senior management have been named as targets of the
government's investigation. In addition, the Company has provided certain
documents to the government. Subsequently, additional interviews with employees
and former employees were conducted by the government; however, the government
has not provided the Company with any documentation from which it may determine
the nature and scope of the investigation.

The Company has established an independent committee of the Board of Directors
to supervise its own investigation. The Company is cooperating fully with the
inquiry and is confident that the Company has not committed any wrongdoings. The
ultimate outcome of this uncertainty cannot presently be determined.
Accordingly, no provision for any liability that may result has been made in the
accompanying condensed consolidated financial statements. Through March 31, 2000
the Company has recorded expenses of $301,000 relating to this matter.

The Company is involved in other legal proceedings and is subject to certain
lawsuits and claims in the ordinary course of its business. Although the
ultimate effect of these matters is often difficult to predict, management
believes that their resolution will not have a material adverse effect on the
Company's condensed consolidated financial statements.

NOTE G - RISKS AND UNCERTAINTIES

The Company receives its nursing home Medicare reimbursement under a new per
diem system known as the prospective payment system (PPS). This new system
entirely changed the way the Company is paid for Medicare Part A services. The
Company's success under this acuity-based system is largely dependent on
managing patient utilization of clinical resources. The Company's ability to
maintain its current level of Medicare reimbursement is uncertain.


                                                                         Page 9.


                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis provides information which management
believes is relevant to an assessment and understanding of the Company's
consolidated results of operations and financial condition. The discussion
should be read in conjunction with the condensed consolidated financial
statements and notes thereto.

Overview

In the fiscal year ended June 30, 1997 the Company reorganized its capital
structure and completed an initial public stock offering (the "Offering") which
raised net proceeds of approximately $4.1 million. In connection with the
Offering, the Company acquired two healthcare businesses, Balz Medical Services,
Inc. and Professional Relief Nurses, Inc.

During the fiscal year ended June 30, 1998, the Company expanded its nursing
home operations with the acquisition of two additional facilities, formed and
began operating two healthcare joint venture companies, and initiated plans to
acquire additional nursing homes.

Under a Management Agreement with SunBridge Healthcare Corporation, effective
November 1, 1998, the Company began providing management services to four
skilled nursing facilities. Growth also continued in its joint-venture ancillary
businesses.

Effective September 1, 1999, the Company acquired the operations of two of the
managed facilities, Adams House and Heritage Heights; the buildings are leased
with an option to purchase. These facilities have a total of 240 skilled nursing
beds. Management contracts covering the two other SunBridge facilities with a
total of 239 skilled nursing beds were terminated as of August 31, 1999 and the
operations of those facilities were returned to SunBridge.

As of January 1, 1999, the Company acquired the remaining 50% membership
interest in one of the above-noted joint ventures, Lexicore Rehab Services,
L.L.C., for a nominal amount plus $120,000 of residual payments. Henceforth the
Company accounted for Lexicore's operations as a wholly-owned subsidiary;
minority interest has been adjusted accordingly.

In January 2000, the Company agreed with its joint venture partner to terminate
operations of Lexicon Pharmacy Services, LLC as of March 31, 2000. The Company
has begun working with an unrelated company to receive pharmaceutical services.

To enhance working capital and liquidity, the Company began negotiations in May
2000 for the sale of the operations of Balz Medical Services, Inc. to an
unrelated company.

The Company believes that the demand for long-term care and specialty medical
services will increase substantially over the next decade due primarily to
favorable demographic trends, advances in medical technology and emphasis on
healthcare cost containment. At the same time, government restrictions and high
construction and start-up costs are expected to limit the supply of long-term
care facilities.


                                                                        Page 10.


                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The Company's operating strategy is to increase nursing home profitability
levels through aggressive marketing and by offering rehabilitation therapies and
other specialized services; by adhering to strict cost standards at the Facility
level while providing effective patient care and containing corporate overhead
expenses; and by becoming a fully integrated health network whereby the Company
will increase marketing of medical products and supplies, rehabilitative
services and nursing services to affiliated and non-affiliated nursing homes and
hospitals, as well as patients at home.

By concentrating its facilities and ancillary service operations within a
selected geographic region, the Company's strategy is to achieve operating
efficiencies through economies of scale, reduced corporate overhead, more
effective management supervision and financial controls. In addition, the
Company believes that geographic concentration also enhances the Company's
ability to establish more effective relationships with referral sources and
regulatory authorities in the states where the Company operates.

YEAR 2000

As of calendar year 2000, the Company is continuing to complete the updating of
its computerized information systems, where necessary, to continue to accurately
process data. The Company experienced no systems failures, major errors, nor any
significant interruptions in its ability to process operating data as a result
of Year 2000 issues.

The Company currently believes that costs of addressing this issue will not have
a material adverse impact on the Company's financial position or results of
operations.

Results of Operations
Three months ended March 31, 2000 ("2000 period") vs. three months ended March
31, 1999 ("1999 period")

For the three months ended March 31, 2000, the Company had total revenues of
$19,463,000 and total expenses of $19,973,000. For the three months ended March
31, 1999, the Company had total revenues of $20,704,000 and total expenses of
$20,722,000. The Company had a net loss of $518,000 or $.15 per share for the
three months ended March 31, 2000 after providing for an income tax benefit of
$2,000. The Company had net income of $47,000 or $.01 per share for the three
months ended March 31, 1999, after providing for an income tax benefit of
$31,000.

For the three months ended March 31, 2000, operating expenses consisted of
salaries and benefits of $14,319,000, food, medical and other supplies of
$2,094,000, and other operating expenses (including rent of $796,000) of
$2,564,000. The Company also had corporate, general and administrative expenses
of $686,000. In addition, income from operations was reduced by interest expense
of $310,000 and net income was reduced by minority interest of $10,000.


                                                                        Page 11.


                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Revenues in the 2000 period decreased over the 1999 period by $1,241,000 or 6%.
Changes in revenues resulted from rate increases (principally Medicaid) and
additional ancillary revenues but were offset by the reduction in management
fees for the two terminated facilities.

Operating expenses in the 2000 period decreased over the 1999 period by $688,000
as a result of expense reductions resulting from managing two fewer nursing
homes in 2000 (as noted above) offset by higher wage and benefit costs resulting
from state-funded Medicaid rate increases. Administrative and general expenses
decreased by $101,000 in the 2000 period consisting mostly of decreases in
subcontracted management fees offset by $67,000 of higher legal costs related to
the government investigation. Interest costs increased by $40,000 as a result of
additional borrowings and higher interest rates.

There was an income tax benefit of $2,000 in the 2000 period on the pre-tax loss
of $520,000. There was an income tax benefit of $31,000 in the 1999 period on
pre-tax income of $16,000; year to date adjustments made in the quarter included
a state tax reduction which produced a non-typical effective rate for the
quarter.

Results of Operations
Nine months ended March 31, 2000 ("2000 period") vs.
nine months ended March 31, 1999 ("1999 period")

For the nine months ended March 31, 2000, the Company had total revenues of
$60,314,000 and total operating expenses of $60,716,000. For the nine months
ended March 31, 1999, the Company had total revenues of $55,717,000 and total
operating expenses of $55,142,000. The Company had a net loss of $513,000 or
$.14 per share for the nine months ended March 31, 2000. The Company had net
income of $230,000 or $.06 per share for the nine months ended March 31, 2000,
after providing for income taxes of $92,000.

For the nine months ended March 31, 2000, operating expenses consisted of
salaries and benefits of $44,038,000, food, medical and other supplies of
$6,295,000, other operating expenses (including rent of $2,305,000) of
$7,126,000, and corporate, general and administrative expenses of $2,367,000. In
addition, the loss from operations was increased by interest expense of $890,000
and net loss was increased by minority interest of $111,000.


                                                                        Page 12.


                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Revenues in the 2000 period increased over the 1999 period by $4,597,000 or 8%.
Changes in revenues resulted from rate increases (principally Medicaid) and
additional ancillary revenues but were offset by the reduction in management
fees for the two terminated facilities.

Operating expenses in the 2000 period increased over the 1999 period by
$5,289,000 or 10% as a result of higher wage and benefit costs resulting from
state-funded Medicaid rate increases, offset by reductions resulting from
managing two fewer nursing homes in 2000 (as noted above). Administrative and
general expenses increased by $146,000, consisting mostly of $301,000 of legal
costs related to the government investigation, offset by decreases in
subcontracted management fees. Interest costs increased by $139,000 as a result
of additional borrowings and higher interest rates.

There was no provision for income taxes in the 2000 period on the net loss of
$513,000. Income taxes of $92,000 were provided in the 1999 period on pre-tax
income of $322,000; the combined federal and state effective rate was 29%.

Liquidity and Capital Resources

Since its formation in 1995, the Company has primarily financed its operations
through operating revenues, borrowings from the prior operator of certain of the
Facilities and other private lenders (including stockholders), by financing its
accounts receivable, through a public offering of its common stock which raised
net proceeds of approximately $4.1 million and through the sale of a portion of
certain bed licenses acquired in 1997.

In July 1997, the Company borrowed $6.8 million in connection with the
acquisition of land, buildings, bed licenses and operating assets of two nursing
homes. Interest is payable at 10% over the 20 year term of the mortgage. In
connection with the acquisitions, the Company also obtained from the seller an
operating subsidy of $2.5 million to be received over five years. As noted
above, some of the bed licenses acquired were sold for $1,550,000 in November
1997.

In July 1995, the Company entered into an agreement to manage the day-to-day
business affairs of Lexington House, Inc., a nursing home with 67 licensed beds;
Lexington House was owned by Jack Friedler, the Company's Chairman and CEO and
his wife.

The Company made certain expenditures on behalf of Lexington House in
anticipation that it would acquire Lexington House. Subsequently, the
negotiations for the sale were terminated because the Company determined that
such facility required too many capital improvements. As of September 30, 1998,
Lexington House, Inc. was indebted to the Company for $649,000 which amount was
formalized into an 8% interest bearing promissory note from Mr. Friedler.

In July 1999, the Company, pursuant to Board of Director's approval, defaulted
the note and seized the collateral of 600,000 shares of the Company's common
stock in satisfaction of the note and interest due. The shares received have
been put into the Company's treasury.


                                                                        Page 13.


                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Liquidity and Capital Resources (Continued)

The 600,000 shares had a market bid price of $731,000 at the time of their
surrender and the note and accumulated interest had a carrying value of
$576,000. The Company's Board of Directors considers the difference between the
market price and carrying value of the note receivable of $155,000 to be a
reasonable and fair discount for the shares received.

In August 1997, the Company obtained a $2,000,000 revolving line of credit from
a bank, which was secured by its accounts receivable and other assets.

In December 1998, the Company refinanced this revolving line of credit with a
$4.5 million financing agreement from a healthcare lender, secured by certain
accounts receivable and other assets. As of March 31, 2000 approximately
$3,603,000 was borrowed under this line of credit. In April 2000 the
availability under this line of credit was increased to $6 million.

To enhance working capital and liquidity, the Company began negotiations in May
2000 for the sale of the operations of Balz Medical Services, Inc. to an
unrelated company.

During the nine months ended March 31, 2000, the Company expended approximately
$246,000 in capital improvements at its leased facilities. Any capital
improvements made to the Facilities belong to the landlord. However, any amounts
expended for capital improvements are generally recouped in their entirety
through the reimbursement system. During the nine months ended March 31, 2000
the Company expended $152,000 for capital improvements at its owned facilities
which was funded by the mortgagor under the terms of the mortgage.

Working capital at March 31, 2000 was $842,000 as compared with working capital
of $955,000 at June 30, 1999. During the nine months ended March 31, 2000 the
Company had made lease deposits in the amount of $147,000 and paid change of
ownership capital expenses of $246,000 at its newly-leased facilities.

At March 31, 2000 the Company had cash and cash equivalents of $1,388,000,
receivables of $15,117,000, inventories of $940,000, prepaid expenses and other
current assets of $1,354,000. Current liabilities at March 31, 2000 consist of
trade accounts payable, amounts due SunBridge Healthcare for accounts receivable
purchased, estimated third-party payor settlements, current portion of notes and
capital leases payable, accrued payroll and related taxes, income taxes, and
other accrued expenses.


                                                                        Page 14.


                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This quarterly report contains certain forward-looking statements regarding the
Company, its business prospects and results of operations that are subject to
certain risks and uncertainties posed by many factors and events that could
cause the Company's actual business, prospects and results of operations to
differ materially from those that may be anticipated by such forward-looking
statements.

Factors that may affect such forward-looking statements include, without
limitations: the Company's ability to successfully and timely develop and
finance new projects, the impact of competition on the Company's revenues,
changes in reimbursement rates, patient mix, and demand for the Company's
services.

When used, words such as "believes," "anticipates," "expects," "intends" and
similar expressions are intended to identify forward-looking statements, but are
not the exclusive means of identifying forward-looking statements. Readers are
cautioned not to place undue reliance on these forward-looking statements, which
speak only as of the date of this report. The Company undertakes no obligation
to revise any forward-looking statements in order to reflect events or
circumstances that may subsequently arise.

Readers are urged to carefully review and consider the various disclosures made
by the Company in this report, news releases, and other reports filed with the
Securities and Exchange Commission that attempt to advise interested parties of
the risks and factors that may affect the Company's business.


                                                                        Page 15.


                           PART II - OTHER INFORMATION

Item 1. Legal Proceedings

In October 1999, the Company announced that certain employees of the Company
were served with a subpoena by the Office of the U.S. Attorney to testify before
a grand jury in the U.S. District Court, District of Connecticut. The Company
and certain members of senior management have been named as targets of the
government's investigation. In addition, the Company has provided certain
documents to the government. Subsequently, additional interviews with employees
and former employees were conducted by the government; however, the government
has not provided the Company with any documentation from which it may determine
the nature and scope of the investigation.

The Company has established an independent committee of the Board of Directors
to supervise its own investigation. The Company is cooperating fully with the
inquiry and is confident that the Company has not committed any wrongdoings. The
ultimate outcome of this uncertainty cannot presently be determined.
Accordingly, no provision for any liability that may result has been made in the
accompanying condensed consolidated financial statements.

The Company had previously disclosed the existence of a lawsuit initiated by the
former President and Administrator of Professional Relief Nurses, Inc. (PRN),
the Company's home care subsidiary, against Lexington Healthcare Group, Inc.,
PRN, and Jack Friedler, the Company's Chairman and CEO, in connection with her
termination in July 1998. In September 1999 the Company settled this suit to
avoid the expenses of protracted litigation. The Company had recorded a
provision for lawsuit settlement of $539,000 in the consolidated statement of
operations during the year ended June 30, 1999. In October 1999, the Company
paid the settlement in full utilizing a previously-posted $350,000 cash bond.

The Company has received notice of lawsuits initiated in early April 2000
against it concerning four nursing homes which it was managing for SunBridge
Healthcare Corporation; the claims are being made by affiliates of SunBridge for
therapy and pharmacy services rendered. The total claimed is $1.2 million of
which $1.1 million is reflected by invoices recorded on the Company's books. The
Company believes that the claim includes overbillings, payments and credits not
applied, and rates charged in excess of contract rates. The Company intends to
vigorously contest the lawsuits as it works out arrangements to pay appropriate
charges.

The Company is involved in other legal proceedings and is subject to certain
lawsuits and claims in the ordinary course of its business. Although the
ultimate effect of these matters is often difficult to predict, management
believes that their resolution will not have a material adverse effect on the
Company.

Item 2. Changes in Securities

                                      NONE

Item 3. Defaults Upon Senior Securities

                                      NONE


                                                                        Page 16.


Item 4. Submission of Matters to a Vote of Security Holders

                                      NONE

Item 5. Other Information

The Company was notified on March 31, 2000 that, since it was no longer in
compliance with the net tangible asset criteria for continued listing on The
Nasdaq SmallCap Market, its securities were delisted from the Nasdaq Stock
Market effective with the open of business April 3, 2000.

Subsequently, the Company's securities have traded on the pink sheets. A broker
dealer has file a Form 15-C-2(11) to list the Company's securities on the NASD
Electronic Bulletin Board.

There can be no assurance that the Company will be successful in its efforts to
become listed on the Electronic Bulletin Board.

Item 6. Exhibits and Reports on Form 8-K

                                      NONE.

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                    /s/ Jack Friedler
                                    ------------------------------------------
                                    (Jack Friedler, Chief Executive Officer)
                                    (Duly Authorized Officer)


                                    /s/ Harry Dermer
                                    ------------------------------------------
                                    (Harry Dermer, President)
                                    (Duly Authorized Officer)


Date  May 15, 2000                  /s/ Thomas E. Dybick
      ------------                  ------------------------------------------
                                    (Thomas E. Dybick, Chief Financial Officer)
                                    (Principal Financial Officer)


                                                                        Page 17.